Slingshot members are tracking this event:

Keryx Biopharmaceuticals' (KERX) Auryxia in treating Iron deficiency anemia in non-dialysis dependent CKD patients PDUFA date expected November 6, 2017.

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
KERX Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 07, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Auryxia, Iron Deficiency Anemia, Chronic Kidney Disease